共 50 条
- [1] XCiDaBLE, a phase IV, prospective observational trial evaluating incobotulinumtoxinA (XEOMIN®) for cervical dystonia or blepharospasm: preliminary baseline data for subjects with blepharospasmEUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 313 - 313LeDoux, M. S.Jankovic, J.Sethi, K.Verma, A.Pappert, E. J.Fernandez, H. H.
- [2] XCiDaBLE: An Observational, Prospective Trial Evaluating Xeomin (IncobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States - Interim Results from the First 145 Subjects with Cervical DystoniaNEUROLOGY, 2013, 80Fernandez, HubertPagan, FernandoDanisi, FabioGreeley, DavidJankovic, JosephVerma, AmitSethi, KapilPappert, Eric
- [3] A Prospective, Observational Trial Evaluating Xeomin [IncobotulinumtoxinA] for Cervical Dystonia or Blepharospasm in the US - Preliminary Baseline Results for Patients with BlepharospasmANNALS OF NEUROLOGY, 2012, 72 : S102 - S103LeDoux, Mark S.Jankovic, JosephSethi, Kapil D.Verma, AmitPappert, Eric J.Fernandez, Hubert H.
- [4] XCiDaBLE: A Phase 4, Observational, Prospective Trial Evaluating Xeomin (IncobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States - Preliminary Baseline Employment History DataNEUROLOGY, 2012, 78Fernandez, HubertDanisi, FabioDaniel TruongPappert, EricVerma, AmitSethi, KapilZadikoff, Cindy
- [5] XCiDaBLE, a phase IV, observational, prospective trial evaluating incobotulinumtoxin A (XEOMIN®) for cervical dystonia or blepharospasm: preliminary baseline results for subjects with cervical dystoniaEUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 667 - 667Truong, D.Danisi, F.Sethi, K.Verma, A.Pappert, E. J.Fernandez, H. H.
- [6] XCiDaBLE: A Phase 4, Observational, Prospective Trial Evaluating Xeomin (IncobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States - Preliminary Baseline Disease Severity and Quality of Life DataNEUROLOGY, 2012, 78LeDoux, MarkLin, DanielJankovic, JosephPappert, EricVerma, AmitSethi, KapilFernandez, Hubert
- [7] XCiDaBLE: A phase 4, observational, prospective trial evaluating incobotulinumtoxinA for cervical dystonia or blepharospasm in the United States - Preliminary baseline results for patients with blepharospasmMOVEMENT DISORDERS, 2012, 27 : S348 - S349LeDoux, M. S.Jankovic, J. J.Sethi, K.Verma, A.Pappert, E. J.Fernandez, H. H.
- [8] A Prospective, Observational Trial Evaluating Xeomin [IncobotulinumtoxinA] for Cervical Dystonia (CD) or Blepharospasm in the United States - Preliminary Baseline Results for Patients with CDANNALS OF NEUROLOGY, 2012, 72 : S103 - S103Truong, Daniel D.Danisi, Fabio O.Sethi, Kapil D.Verma, AmitPappert, Eric J.Fernandez, Hubert H.
- [9] Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with BlepharospasmTREMOR AND OTHER HYPERKINETIC MOVEMENTS, 2014, 4Fernandez, Hubert H.Jankovic, JosephHolds, John B.Lin, DanielBurns, JohnVerma, AmitSethi, KapilPappert, Eric J.
- [10] XCiDaBLE: A phase 4, observational, prospective trial evaluating incobotulinumtoxinA for cervical dystonia (CD) or blepharospasm in the United States - Preliminary baseline results for patients with CDMOVEMENT DISORDERS, 2012, 27 : S368 - S369Truong, D.Danisi, F.Sethi, K.Verma, A.Pappert, E. J.Fernandez, H. H.